Company Overview of VLST Corporation
VLST Corporation discovers and develops therapeutics for the treatment of inflammatory and autoimmune disorders. The company provides VLST-007 (hCD47-hFc), a dimeric protein for the treatment of inflammatory and autoimmune diseases; VLST-002 (AntiKine Ab) multi-reactive anti-chemokine antibodies for the treatment of autoimmune and inflammatory diseases; and Hepatitis C virus antiviral products. Its discovery platform has primary applications for the treatment of inflammatory and autoimmune diseases such as rheumatoid arthritis, Crohn’s disease, multiple sclerosis, lupus, and diabetes. The company was founded in 2004 and is headquartered in Seattle, Washington.
307 Westlake Avenue North
Seattle, WA 98109
Founded in 2004
Key Executives for VLST Corporation
Similar Private Companies By Industry
|Direct Spinal Therapeutics, Inc.||United States|
|RAPiD Genomics LLC||United States|
|Gibson Laboratories, LLC||United States|
|Sophion Bioscience Inc.||United States|
|JRX Biotechnology, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact VLST Corporation, please visit www.vlstcorp.com. Company data is provided by Capital IQ. Please use this form to report any data issues.